ZENDAL

MTBVAC

Vaccines
Cancer
MTBVAC is a live freeze dried vaccine based on a genetically attenuated strain of a clinical isolate of M. tuberculosis manufactured by BIOFABRI. MTBVAC is now in Phase 2a in newborns infants and a Phase2a in BCG-vaccinated adults in South Africa
2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical